Rho Kinase Inhibitor

Aka: Rho Kinase Inhibitor, Netarsudil, Rhopressa

advertisement

II. Indications

  1. Open Angle Glaucoma

III. Contraindications

  1. Active Uveitis

IV. Mechanism

  1. New, expensive class of Open Angle Glaucoma medication released in U.S., 2018
  2. Increases ocular fluid overflow and decreases Episcleral venous pressure (lowers IOP 10-20%)

V. Medications (white cap)

  1. Netarsudil (Rhopressa) once daily

VI. Adverse Effects

  1. Eye Redness with Conjunctival Hyperemia (>50% of patients)
  2. Blurred Vision
  3. Keratitis
  4. Cornea Verticillata

VII. References

  1. (2018) Presc Lett 25(5):28
  2. Harris (2023) Am Fam Physician 107(3): 238-46 [PubMed]

Images: Related links to external sites (from Bing)

These images are a random sampling from a Bing search on the term "Rho Kinase Inhibitor." Click on the image (or right click) to open the source website in a new browser window. Search Bing for all related images

Related Studies

Cost: Medications

rhopressa (on 1/3/2022 at Medicaid.Gov Survey of pharmacy drug pricing)
RHOPRESSA 0.02% OPHTH SOLUTION $114.09 per ml
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information. GoodRx is another tool for finding lower drug prices.

Related Topics in Pharmacology

advertisement